Recorded but not shown as evidence until the reason below is resolved.
Affinity of the best binder found per target (Adaptyv EGFR competition, third-party BLI)
Withheld: a cited source is unchecked or has evidence concerns; a source the use case cites is unchecked or has evidence concerns; protocol evidence is disputed or unchecked; a reviewed evaluation is no longer eligible (uc-binder-20261022-eval-adaptyv-bindcraft-r1-affinity, uc-binder-20261022-eval-adaptyv-bindcraft-r2-affinity, uc-binder-20261022-eval-adaptyv-cradle-r2-affinity); no evaluation on the protocol is eligible evidence.
One target, one assay, many methods (EGFR) (Adaptyv EGFR competition rounds 1 and 2)
Withheld: a cited source is unchecked or has evidence concerns; a source the use case cites is unchecked or has evidence concerns; protocol evidence is disputed or unchecked; a reviewed evaluation is no longer eligible (uc-binder-20261022-eval-adaptyv-bindcraft-gb1-binding, uc-binder-20261022-eval-adaptyv-both-binding, uc-binder-20261022-eval-adaptyv-r1-binding, uc-binder-20261022-eval-adaptyv-r2-binding); no evaluation on the protocol is eligible evidence.
Attrition between a screen hit and a confirmed binder (Adaptyv EGFR competition, third-party cell-free expression)
Withheld: a cited source is unchecked or has evidence concerns; a source the use case cites is unchecked or has evidence concerns; protocol evidence is disputed or unchecked; a reviewed evaluation is no longer eligible (uc-binder-20261022-eval-adaptyv-bindcraft-gb1-expression, uc-binder-20261022-eval-adaptyv-bindcraft-r1-expression, uc-binder-20261022-eval-adaptyv-bindcraft-r2-expression, uc-binder-20261022-eval-adaptyv-r1-expression, uc-binder-20261022-eval-adaptyv-r2-expression); no evaluation on the protocol is eligible evidence.
Attrition between a screen hit and a confirmed binder (AlphaProteo yeast hits through E. coli expression and HTRF)
Withheld: a cited source is unchecked or has evidence concerns; a source the use case cites is unchecked or has evidence concerns; protocol evidence is disputed or unchecked; a reviewed evaluation is no longer eligible (uc-binder-20261022-eval-alphaproteo-s3-observed-htrf-binding-bhrf1, uc-binder-20261022-eval-alphaproteo-s3-observed-htrf-binding-il17a, uc-binder-20261022-eval-alphaproteo-s3-observed-htrf-binding-il7ra, uc-binder-20261022-eval-alphaproteo-s3-observed-htrf-binding-pdl1, uc-binder-20261022-eval-alphaproteo-s3-observed-htrf-binding-sc2rbd); no evaluation on the protocol is eligible evidence.
Affinity of the best binder found per target (AlphaProteo and published RFdiffusion designs, HTRF)
Withheld: a cited source is unchecked or has evidence concerns; a source the use case cites is unchecked or has evidence concerns; protocol evidence is disputed or unchecked; a reviewed evaluation is no longer eligible (uc-binder-20261022-eval-alphaproteo-s2-kd-rfdiffusion-published-designs-il7ra-main, uc-binder-20261022-eval-alphaproteo-s2-kd-rfdiffusion-published-designs-pdl1-main, uc-binder-20261022-eval-alphaproteo-s2-kd-rfdiffusion-published-designs-trka-main, uc-binder-20261022-eval-alphaproteo-s2-kd-v1-bhrf1-main, uc-binder-20261022-eval-alphaproteo-s2-kd-v1-il17a-main); no evaluation on the protocol is eligible evidence.
Miniprotein binder hit rates by target (AlphaProteo and published RFdiffusion designs, yeast display at signal above 0.2)
Withheld: a cited source is unchecked or has evidence concerns; a source the use case cites is unchecked or has evidence concerns; protocol evidence is disputed or unchecked; a reviewed evaluation is no longer eligible (uc-binder-20261022-eval-alphaproteo-s2-rate-rfdiffusion-published-designs-il7ra-main, uc-binder-20261022-eval-alphaproteo-s2-rate-rfdiffusion-published-designs-pdl1-main, uc-binder-20261022-eval-alphaproteo-s2-rate-rfdiffusion-published-designs-trka-main, uc-binder-20261022-eval-alphaproteo-s2-rate-v1-bhrf1-main, uc-binder-20261022-eval-alphaproteo-s2-rate-v1-il7ra-main); no evaluation on the protocol is eligible evidence.
Miniprotein binder hit rates by target (AlphaProteo on IL-17A, yeast display at signal above 1.3)
Withheld: a cited source is unchecked or has evidence concerns; a source the use case cites is unchecked or has evidence concerns; protocol evidence is disputed or unchecked; a reviewed evaluation is no longer eligible (uc-binder-20261022-eval-alphaproteo-s2-rate-v1-il17a-main, uc-binder-20261022-eval-alphaproteo-table1-rate-il17a); no evaluation on the protocol is eligible evidence.
Computational filters used to choose which designs to test (AlphaFold3 filter pass rates)
Withheld: protocol evidence is disputed or unchecked; a reviewed evaluation is no longer eligible (uc-binder-20261022-eval-bennett-h1stem-spr-insilico-af3-af3, uc-binder-20261022-eval-bennett-h1stem-ysd-insilico-af3-af3, uc-binder-20261022-eval-bennett-il7r-spr-insilico-af3-af3, uc-binder-20261022-eval-bennett-rbd-ysd-insilico-af3-af3, uc-binder-20261022-eval-bennett-rsv3-ysd-insilico-af3-af3).
Computational filters used to choose which designs to test (Fine-tuned RoseTTAFold2 filter pass rates)
Withheld: protocol evidence is disputed or unchecked; a reviewed evaluation is no longer eligible (uc-binder-20261022-eval-bennett-h1stem-spr-insilico-rf2-0-0, uc-binder-20261022-eval-bennett-h1stem-spr-insilico-rf2-0-1, uc-binder-20261022-eval-bennett-h1stem-spr-insilico-rf2-1, uc-binder-20261022-eval-bennett-h1stem-ysd-insilico-rf2-0-0, uc-binder-20261022-eval-bennett-h1stem-ysd-insilico-rf2-0-1).
Antibody variable-domain hit rates by target (Fine-tuned RFdiffusion VHHs, 96 designs per target by SPR)
Withheld: a cited source is unchecked or has evidence concerns; a source the use case cites is unchecked or has evidence concerns; protocol evidence is disputed or unchecked; a reviewed evaluation is no longer eligible (uc-binder-20261022-eval-bennett-h1stem-spr, uc-binder-20261022-eval-bennett-il7r-spr, uc-binder-20261022-eval-bennett-tcdb-spr); no evaluation on the protocol is eligible evidence.
Antibody variable-domain hit rates by target (Fine-tuned RFdiffusion VHHs, 9,000 designs per target by yeast display)
Withheld: a cited source is unchecked or has evidence concerns; a source the use case cites is unchecked or has evidence concerns; protocol evidence is disputed or unchecked; a reviewed evaluation is no longer eligible (uc-binder-20261022-eval-bennett-h1stem-ysd, uc-binder-20261022-eval-bennett-rbd-ysd, uc-binder-20261022-eval-bennett-rsv3-ysd); no evaluation on the protocol is eligible evidence.
Affinity of the best binder found per target (BindCraft, SPR and BLI)
Withheld: a cited source is unchecked or has evidence concerns; a source the use case cites is unchecked or has evidence concerns; protocol evidence is disputed or unchecked; a reviewed evaluation is no longer eligible (uc-binder-20261022-eval-bindcraft-affinity-bbf14, uc-binder-20261022-eval-bindcraft-affinity-betv1, uc-binder-20261022-eval-bindcraft-affinity-cbago, uc-binder-20261022-eval-bindcraft-affinity-cd45, uc-binder-20261022-eval-bindcraft-affinity-crsas6); no evaluation on the protocol is eligible evidence.
Miniprotein binder hit rates by target (BindCraft per-target binding screens)
Withheld: a cited source is unchecked or has evidence concerns; a source the use case cites is unchecked or has evidence concerns; protocol evidence is disputed or unchecked; a reviewed evaluation is no longer eligible (uc-binder-20261022-eval-bindcraft-screen-bbf14, uc-binder-20261022-eval-bindcraft-screen-betv1, uc-binder-20261022-eval-bindcraft-screen-cbago, uc-binder-20261022-eval-bindcraft-screen-cd45, uc-binder-20261022-eval-bindcraft-screen-cldn1); no evaluation on the protocol is eligible evidence.
Miniprotein binder hit rates by target (BindCraft average over 12 targets)
Withheld: a cited source is unchecked or has evidence concerns; a source the use case cites is unchecked or has evidence concerns; protocol evidence is disputed or unchecked; a reviewed evaluation is no longer eligible (uc-binder-20261022-eval-bindcraft-aggregate-12-targets); no evaluation on the protocol is eligible evidence.